63 related articles for article (PubMed ID: 3780837)
1. Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
Chetboul V; Pouchelon JL; Menard J; Blanc J; Desquilbet L; Petit A; Rougier S; Lucats L; Woehrle F;
J Vet Intern Med; 2017 Nov; 31(6):1629-1642. PubMed ID: 28975664
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Critical Review of Clinical Pharmacokinetics of Torasemide.
Sherazi AW; Zamir A; Rehman AU; Ashraf W; Imran I; Saeed H; Majeed A; Saleem Z; Aziz M; Alqahtani F; Rasool MF
Ther Drug Monit; 2024 Jun; 46(3):309-320. PubMed ID: 38176856
[TBL] [Abstract][Full Text] [Related]
3. Effect of diuretic drugs on creatinine clearance determination.
Lam NP; Kuk JM; Franson KL; Lau AH
Ther Drug Monit; 1995 Apr; 17(2):142-4. PubMed ID: 7624902
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of the pharmacokinetics of continuous magnesium infusion in critically ill patients.
Chan JW; Yanase F; See E; McCue C; Yong ZT; Talbot LJ; Flanagan JPM; Eastwood GM
Crit Care Resusc; 2022 Mar; 24(1):29-38. PubMed ID: 38046838
[No Abstract] [Full Text] [Related]
5. Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria.
Takagi K; Sato N; Ishihara S; Sone M; Tokuyama H; Nakama K; Omote T; Kikuchi A; Ishikawa M; Amitani K; Takahashi N; Maruyama Y; Imura H; Shimizu W
Heart Vessels; 2018 Apr; 33(4):413-420. PubMed ID: 29063302
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics and pharmacodynamics of torasemide.
Knauf H; Mutschler E
Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
[TBL] [Abstract][Full Text] [Related]
7. Torasemide. A review of its pharmacological properties and therapeutic potential.
Friedel HA; Buckley MM
Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
[TBL] [Abstract][Full Text] [Related]
8. Torasemide in advanced renal failure.
Kindler J
Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():75-80. PubMed ID: 8435381
[TBL] [Abstract][Full Text] [Related]
9. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
Kido H; Ohtaki Y
Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
Dodion L; Ambroes Y; Lameire N
Eur J Clin Pharmacol; 1986; 31 Suppl():21-7. PubMed ID: 3780837
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic effects of torasemide in healthy volunteers.
Lameire N; Dodion L
Arzneimittelforschung; 1988 Jan; 38(1A):167-71. PubMed ID: 3370064
[TBL] [Abstract][Full Text] [Related]
12. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS
Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838
[TBL] [Abstract][Full Text] [Related]
13. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology of torasemide, a new loop diuretic.
Brater DC; Leinfelder J; Anderson SA
Clin Pharmacol Ther; 1987 Aug; 42(2):187-92. PubMed ID: 3608350
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
